New Zealand to establish fit for purpose regulation for new psychoactive substances

Brendan Hughes, Adam R. Winstock, Controlling new drugs under marketing regulations Addiction. ,vol. 107, pp. 1894- 1899 ,(2012) , 10.1111/J.1360-0443.2011.03620.X

David Nutt, Government vs science over drug and alcohol policy. The Lancet. ,vol. 374, pp. 1731- 1733 ,(2009) , 10.1016/S0140-6736(09)61956-5

Wayne Hall, Psychoactive drugs of misuse: rationalising the irrational. The Lancet. ,vol. 369, pp. 972- 972 ,(2007) , 10.1016/S0140-6736(07)60471-1

Janie Sheridan, Rachael Butler, "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand? International Journal of Drug Policy. ,vol. 21, pp. 77- 81 ,(2010) , 10.1016/J.DRUGPO.2009.02.002

Adam Winstock, Luke Mitcheson, John Marsden, Mephedrone: still available and twice the price The Lancet. ,vol. 376, pp. 1537- 1537 ,(2010) , 10.1016/S0140-6736(10)62021-1

Fiona Measham, Karenza Moore, Russell Newcombe, Zoë (née Smith), Tweaking, bombing, dabbing and stockpiling: the emergence of mephedrone and the perversity of prohibition Drugs and Alcohol Today. ,vol. 10, pp. 14- 21 ,(2010) , 10.5042/DAAT.2010.0123

Adam R. Winstock, Luke R. Mitcheson, Paolo Deluca, Zoe Davey, Ornella Corazza, Fabrizio Schifano, Mephedrone, new kid for the chop? Addiction. ,vol. 106, pp. 154- 161 ,(2011) , 10.1111/J.1360-0443.2010.03130.X